Navigation Links
Confusion Prevails Over the Risk and Benefits of Hormone Therapy

Hormone therapy mainly consisted of Estrogen-only or estrogen plus progestin. It was mainly prescribed for women treat menopausal symptoms//. It was originally prescribed to quell hot flashes and other symptoms of menopause, but there were also indications that the therapy lowered the risks of heart disease, bone loss and possibly other ailments. Hormone replacement therapy came under scrutiny when research called the Women's Health Initiative study was terminated early, in February 2004, because of unexpected findings that women faced heightened risks of ailments including stroke, blood clots and breast cancer. Since then, further analysis of the WHI study data and other studies has generated confusion.

But a recent study said that hormone replacement therapy used to treat symptoms of menopause does not raise the risk of breast cancer for women who have had a hysterectomy. The finding contrasts with the higher risk of breast cancer among menopausal women taking estrogen plus progestin which is a combination designed to protect against uterine cancer. In hysterectomy all or part of the uterus is removed. Dr. Elizabeth Nabel, director of the National Heart, Lung, and Blood Institute of the National Institutes of Health, which sponsored the WHI study said that hormone therapy should only be used to treat menopausal symptoms and should be used at the smallest effective dose for the shortest possible time. After the WHI study was published, sales of Wyeth's leading hormone replacement drugs Premarin and Prempro fell dramatically.

A new study done by Marcia Stefanik of Stanford University was published in the Journal of the American Medical Association, covered nearly 11,000 women participating in the WHI study who had a hysterectomy. It was found that there were fewer breast cancers diagnosed for women on the active study pills when compared to those taking harmless sugar pills. But the tumors were significantly larger and had a tendency to spread to more lymph nodes. The women taking estrogen had slightly fewer breast cancers but they had more follow-up mammograms and biopsies performed. The hormone tends to make breast tissue denser and therefore more difficult to detect tumors. Hence there still exists some sort of confusion over the effectiveness and safety of the therapy.


'"/>




Related medicine news :

1. Drug Name Confusion Makes Imports Dangerous: FDA
2. Confusion persists in the case of whole grains
3. To Eat Or Not To Eat: Confusion Over Tandoori Chicken
4. Cancer Confusion over Kylie effect
5. Kerala: God’s Own Country Prevails Against AID
6. Benefits in fertility procedures
7. Benefits of Vitamin Supplements Unclear
8. Benefits of Eating Whole Grains, Fruits and Vegetables
9. Benefits of Nitric Oxide in the Treatment of Premature Infants
10. Benefits and Risks of Asthma Treatment Questioned
11. Benefits Of The Worlds Most Widely Used Beverage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: